
Education
Departmental Seminar: Noveome Biotherapeutics, Inc.
Ends:
Mellon Institute (MCS)
Free
Guest Speaker: Ziv Kirshner, PhD Noveome Biotherapeutics, Inc. “An Emerging Cell-Free Paradigm: Developing a Multifactorial Secretome to Treat Preterm Infants with Necrotizing Enterocolitis (NEC)” Dr. Ziv Kirshner is a biopharmaceutical scientist specializing in the development and clinical translation of complex biological therapeutics, particularly cell-secreted and secretome-based medicines. He serves as Senior Director of Manufacturing and Senior Director of Advanced Analytical Sciences at Noveome Biotherapeutics, where he leads CMC strategy, process development, GMP manufacturing, and advanced analytical characterization using mass spectrometry and multiomics. His recent work includes the development and clinical advancement of ST266, an amnion-derived secretome therapeutic being investigated for multiple indications, including necrotizing enterocolitis (NEC) in premature infants. He also co-founded Noveome Analytics LLC, a boutique contract analytical services company established to expand access to advanced HPLC and mass spectrometry capabilities for regional biopharma and academic research.
Sources: cmu_events
